Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices

Circulation: Heart Failure

Volumn 9, Issue 5, 2016, Pages

  Nassif, Michael E ^a   LaRue, Shane J ^a   Raymer, David S ^a   Novak, Eric ^a   Vader, Justin M ^a   Ewald, Gregory A ^a   Gage, Brian F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; follow up studies; hemorrhage; international normalized ratio stroke

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CORRELATION ANALYSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PUMP THROMBOSIS; RETROSPECTIVE STUDY; THROMBOSIS; ADOLESCENT; ADVERSE EFFECTS; BLOOD; BLOOD CLOTTING; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG MONITORING; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; INTRACRANIAL THROMBOSIS; MIDDLE AGED; MISSOURI; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSTHESIS DESIGN; RISK FACTOR; STROKE; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; DRUG MONITORING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGES; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; MISSOURI; MULTIVARIATE ANALYSIS; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84969261943     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.002680     Document Type: Article

References (25)

1. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Timothy Baldwin J, Young JB, Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 2013 32 141 156. doi: 10.1016/j.healun.2012.12.004
2. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH, HeartMate II Investigators Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 361 2241 2251. doi: 10.1056/NEJMoa0909938
3. Griffith BP, Kormos RL, Borovetz HS, Litwak K, Antaki JF, Poirier VL, Butler KC, HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 2001 71 3 suppl S116 S120; discussion S114-S116
4. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, Frazier OH, Heatley G, Farrar DJ, John R, Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009 28 881 887. doi: 10.1016/j.healun.2009.05.018
5. John R, Kamdar F, Liao K, Colvin-Adams M, Miller L, Joyce L, Boyle A, Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg 2008 136 1318 1323. doi: 10.1016/j.jtcvs.2007.12.077
6. Najjar SS, Slaughter MS, Pagani FD, Starling RC, McGee EC, Eckman P, Tatooles AJ, Moazami N, Kormos RL, Hathaway DR, Najarian KB, Bhat G, Aaronson KD, Boyce SW, HVAD Bridge to Transplant ADVANCE Trial Investigators An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2014 33 23 34. doi: 10.1016/j.healun.2013.12.001
7. Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG, Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014 370 33 40. doi: 10.1056/NEJMoa1313385
8. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Acker MA, Goldstein DL, Silvestry SC, Milano CA, Baldwin JT, Timothy Baldwin J, Pinney S, Eduardo Rame J, Miller MA, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 2014 33 12 22. doi: 10.1016/j.healun.2013.11.001
9. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009 42 377 381. doi: 10.1016/j.jbi.2008.08.010
10. Shah P, Mehta VM, Cowger JA, Aaronson KD, Pagani FD, Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. J Heart Lung Transplant 2014 33 102 104. doi: 10.1016/j.healun.2013.07.013
11. Willey JZ, Demmer RT, Takayama H, Colombo PC, Lazar RM, Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: risk factors, diagnosis, and treatment. J Heart Lung Transplant 2014 33 878 887. doi: 10.1016/j.healun.2014.05.005
12. Morgan JA, Brewer RJ, Nemeh HW, Gerlach B, Lanfear DE, Williams CT, Paone G, Stroke while on long-Term left ventricular assist device support: incidence, outcome, and predictors. ASAIO J 2014 60 284 289. doi: 10.1097/MAT.0000000000000074
13. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ, Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-Analysis. Lancet Neurol 2010 9 167 176. doi: 10.1016/S1474-4422(09)70340-0
14. Morgan JA, Paone G, Nemeh HW, Henry SE, Patel R, Vavra J, Williams CT, Lanfear DE, Tita C, Brewer RJ, Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2012 31 715 718. doi: 10.1016/j.healun.2012.02.015
15. Kushnir VM, Sharma S, Ewald GA, Seccombe J, Novak E, Wang IW, Joseph SM, Gyawali CP, Evaluation of GI bleeding after implantation of left ventricular assist device. Gastrointest Endosc 2012 75 973 979. doi: 10.1016/j.gie.2011.12.014
16. Aggarwal A, Pant R, Kumar S, Sharma P, Gallagher C, Tatooles AJ, Pappas PS, Bhat G, Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012 93 1534 1540. doi: 10.1016/j.athoracsur.2012.02.035
17. Nassif ME, Patel JS, Shuster JE, Raymer DS, Jackups R Jr, Novak E, Gage BF, Prasad S, Silvestry SC, Ewald GA, LaRue SJ, Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device. JACC Heart Fail 2015 3 146 153. doi: 10.1016/j.jchf.2014.08.005
18. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E, A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993 69 236 239
19. Maxwell EA, Analysis of contingency tables and further reasons for not using Yates correction in 2×2 tables. Can J Stat 1976 4 277 290
20. Stulak JM, Deo S, Schirger J, Aaronson KD, Park SJ, Joyce LD, Daly RC, Pagani FD, Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg 2013 96 2161 2167. doi: 10.1016/j.athoracsur.2013.07.004
21. Whitson BA, Eckman P, Kamdar F, Lacey A, Shumway SJ, Liao KK, John R, Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients. Ann Thorac Surg 2014 97 2097 2103. doi: 10.1016/j.athoracsur.2014.02.041
22. Rame JE, Atluri P, Acker MA, Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014 370 1466 1467. doi: 10.1056/NEJMc1402425
23. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D, Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-Term support and at the time of transplantation. J Am Coll Cardiol 2010 56 1207 1213. doi: 10.1016/j.jacc.2010.05.016
24. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Myers S, Acker MA, Rogers J, Slaughter MS, Stevenson LW, Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry. J Heart Lung Transplant 2015 34 1515 1526. doi: 10.1016/j.healun.2015.10.024
25. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS, The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009 151 297 305